Astria Therapeutics, Inc. (ATXS) Misses Q1 EPS by 3c

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q1 EPS of ($0.38), $0.03 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Piper Sandler: 'Amazon.com (AMZN) AMZN Looks Best Positioned'
• C1 Fund reports portfolio growth and share repurchase activity